newsfilter
← Latest News
GlobeNewswire·

LAVA Therapeutics Announces Appointment of Fred M. Powell as Chief Financial Officer

UTRECHT, The Netherlands and PHILADELPHIA, Nov. 01, 2022 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ:LVTX), a clinical stage immuno-oncology company focused on developing its proprietary Gammabody™